{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,18]],"date-time":"2026-08-18T02:30:23Z","timestamp":1787020223184,"version":"build-2736575974"},"reference-count":19,"publisher":"Springer Science and Business Media LLC","issue":"1","funder":[{"DOI":"10.13039\/501100003052","name":"Ministry of Trade, Industry and Energy","doi-asserted-by":"publisher","award":["10053626"],"award-info":[{"award-number":["10053626"]}],"id":[{"id":"10.13039\/501100003052","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Med Genet"],"published-print":{"date-parts":[[2018,12]]},"DOI":"10.1186\/s12881-018-0546-4","type":"journal-article","created":{"date-parts":[[2018,3,5]],"date-time":"2018-03-05T06:34:04Z","timestamp":1520231644000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":22,"title":["A case of an infant suspected as IMAGE syndrome who were finally diagnosed with MIRAGE syndrome by targeted Mendelian exome sequencing"],"prefix":"10.1186","volume":"19","author":[{"given":"Yoon-Myung","family":"Kim","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Go Hun","family":"Seo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gu-Hwan","family":"Kim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jung Min","family":"Ko","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jin-Ho","family":"Choi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8615-186X","authenticated-orcid":false,"given":"Han-Wook","family":"Yoo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2018,3,5]]},"reference":[{"key":"546_CR1","doi-asserted-by":"publisher","first-page":"364","DOI":"10.1210\/jc.2015-1710","volume":"101","author":"SR Bornstein","year":"2016","unstructured":"Bornstein SR, Allolio B, Arlt W, Barthel A, Don-Wauchope A, Hammer GD, et al. Diagnosis and treatment of primary adrenal insufficiency: an Endocrine Society clinical practice guideline. J Clin Endocrinol Metab. 2016;101:364\u201389.","journal-title":"J Clin Endocrinol Metab"},{"key":"546_CR2","doi-asserted-by":"publisher","first-page":"284","DOI":"10.1210\/jc.2015-3250","volume":"101","author":"T Guran","year":"2016","unstructured":"Guran T, Buonocore F, Saka N, Ozbek MN, Aycan Z, Bereket A, et al. Rare causes of primary adrenal insufficiency: genetic and clinical characterization of a large Nationwide cohort. J Clin Endocrinol Metab. 2016;101:284\u201392.","journal-title":"J Clin Endocrinol Metab"},{"key":"546_CR3","doi-asserted-by":"publisher","first-page":"145","DOI":"10.1159\/000363107","volume":"82","author":"J Malikova","year":"2014","unstructured":"Malikova J, Fluck CE. Novel insight into etiology, diagnosis and management of primary adrenal insufficiency. Horm Res Paediatr. 2014;82:145\u201357.","journal-title":"Horm Res Paediatr"},{"key":"546_CR4","first-page":"113","volume":"6","author":"LF Chan","year":"2015","unstructured":"Chan LF, Campbell DC, Novoselova TV, Clark AJ, Metherell LA. Whole-exome sequencing in the differential diagnosis of primary adrenal insufficiency in children. Front Endocrinol (Lausanne). 2015;6:113.","journal-title":"Front Endocrinol (Lausanne)"},{"key":"546_CR5","doi-asserted-by":"publisher","first-page":"607","DOI":"10.1016\/j.beem.2015.07.004","volume":"29","author":"JP Suntharalingham","year":"2015","unstructured":"Suntharalingham JP, Buonocore F, Duncan AJ, Achermann JC. DAX-1 (NR0B1) and steroidogenic factor-1 (SF-1, NR5A1) in human disease. Best Pract Res Clin Endocrinol Metab. 2015;29:607\u201319.","journal-title":"Best Pract Res Clin Endocrinol Metab"},{"key":"546_CR6","doi-asserted-by":"publisher","first-page":"38","DOI":"10.1159\/000321213","volume":"20","author":"R El-Khairi","year":"2011","unstructured":"El-Khairi R, Martinez-Aguayo A, Ferraz-de-Souza B, Lin L, Achermann JC. Role of DAX-1 (NR0B1) and steroidogenic factor-1 (NR5A1) in human adrenal function. Endocr Dev. 2011;20:38\u201346.","journal-title":"Endocr Dev"},{"key":"546_CR7","doi-asserted-by":"publisher","first-page":"706","DOI":"10.1111\/cen.12379","volume":"80","author":"F Kato","year":"2014","unstructured":"Kato F, Hamajima T, Hasegawa T, Amano N, Horikawa R, Nishimura G, et al. IMAGe syndrome: clinical and genetic implications based on investigations in three Japanese patients. Clin Endocrinol. 2014;80:706\u201313.","journal-title":"Clin Endocrinol"},{"key":"546_CR8","doi-asserted-by":"publisher","first-page":"788","DOI":"10.1038\/ng.2275","volume":"44","author":"VA Arboleda","year":"2012","unstructured":"Arboleda VA, Lee H, Parnaik R, Fleming A, Banerjee A, Ferraz-de-Souza B, et al. Mutations in the PCNA-binding domain of CDKN1C cause IMAGe syndrome. Nat Genet. 2012;44:788\u201392.","journal-title":"Nat Genet"},{"key":"546_CR9","doi-asserted-by":"publisher","first-page":"19","DOI":"10.1159\/000134753","volume":"13","author":"B Ferraz-de-Souza","year":"2008","unstructured":"Ferraz-de-Souza B, Achermann JC. Disorders of adrenal development. Endocr Dev. 2008;13:19\u201332.","journal-title":"Endocr Dev"},{"key":"546_CR10","doi-asserted-by":"publisher","first-page":"792","DOI":"10.1038\/ng.3569","volume":"48","author":"S Narumi","year":"2016","unstructured":"Narumi S, Amano N, Ishii T, Katsumata N, Muroya K, Adachi M, et al. SAMD9 mutations cause a novel multisystem disorder, MIRAGE syndrome, and are associated with loss of chromosome 7. Nat Genet. 2016;48:792\u20137.","journal-title":"Nat Genet"},{"key":"546_CR11","doi-asserted-by":"publisher","first-page":"1700","DOI":"10.1172\/JCI91913","volume":"127","author":"F Buonocore","year":"2017","unstructured":"Buonocore F, Kuhnen P, Suntharalingham JP, Del Valle I, Digweed M, Stachelscheid H, et al. Somatic mutations and progressive monosomy modify SAMD9-related phenotypes in humans. J Clin Invest. 2017;127:1700\u201313.","journal-title":"J Clin Invest"},{"key":"546_CR12","doi-asserted-by":"publisher","unstructured":"Shima H, Koehler K, Nomura Y, Sugimoto K, Satoh A, Ogata T, et al. Two patients with MIRAGE syndrome lacking haematological features: role of somatic second-site reversion SAMD9 mutations. J Med Genet. 2017; \n                    https:\/\/doi.org\/10.1136\/jmedgenet-2017-105020\n                    \n                  .","DOI":"10.1136\/jmedgenet-2017-105020"},{"key":"546_CR13","doi-asserted-by":"publisher","first-page":"662","DOI":"10.1038\/jid.2010.387","volume":"131","author":"D Hershkovitz","year":"2011","unstructured":"Hershkovitz D, Gross Y, Nahum S, Yehezkel S, Sarig O, Uitto J, et al. Functional characterization of SAMD9, a protein deficient in normophosphatemic familial tumoral calcinosis. J Invest Dermatol. 2011;131:662\u20139.","journal-title":"J Invest Dermatol"},{"key":"546_CR14","doi-asserted-by":"publisher","first-page":"305","DOI":"10.1016\/j.ccr.2013.08.011","volume":"24","author":"A Nagamachi","year":"2013","unstructured":"Nagamachi A, Matsui H, Asou H, Ozaki Y, Aki D, Kanai A, et al. Haploinsufficiency of SAMD9L, an endosome fusion facilitator, causes myeloid malignancies in mice mimicking human diseases with monosomy 7. Cancer Cell. 2013;24:305\u201317.","journal-title":"Cancer Cell"},{"key":"546_CR15","doi-asserted-by":"publisher","first-page":"92","DOI":"10.1186\/1471-2164-8-92","volume":"8","author":"CF Li","year":"2007","unstructured":"Li CF, MacDonald JR, Wei RY, Ray J, Lau K, Kandel C, et al. Human sterile alpha motif domain 9, a novel gene identified as down-regulated in aggressive fibromatosis, is absent in the mouse. BMC Genomics. 2007;8:92.","journal-title":"BMC Genomics"},{"key":"546_CR16","doi-asserted-by":"publisher","first-page":"1260419","DOI":"10.1126\/science.1260419","volume":"347","author":"M Uhlen","year":"2015","unstructured":"Uhlen M, Fagerberg L, Hallstrom BM, Lindskog C, Oksvold P, Mardinoglu A, et al. Proteomics. Tissue-based map of the human proteome. Science. 2015;347:1260419.","journal-title":"Science"},{"key":"546_CR17","doi-asserted-by":"publisher","first-page":"1423","DOI":"10.1038\/sj.jid.5701203","volume":"128","author":"I Chefetz","year":"2008","unstructured":"Chefetz I, Ben Amitai D, Browning S, Skorecki K, Adir N, Thomas MG, et al. Normophosphatemic familial tumoral calcinosis is caused by deleterious mutations in SAMD9, encoding a TNF-alpha responsive protein. J Invest Dermatol. 2008;128:1423\u20139.","journal-title":"J Invest Dermatol"},{"key":"546_CR18","doi-asserted-by":"publisher","first-page":"759","DOI":"10.1086\/508069","volume":"79","author":"O Topaz","year":"2006","unstructured":"Topaz O, Indelman M, Chefetz I, Geiger D, Metzker A, Altschuler Y, et al. A deleterious mutation in SAMD9 causes normophosphatemic familial tumoral calcinosis. Am J Hum Genet. 2006;79:759\u201364.","journal-title":"Am J Hum Genet"},{"key":"546_CR19","doi-asserted-by":"publisher","first-page":"157","DOI":"10.1016\/j.bbrc.2014.10.054","volume":"454","author":"Q Ma","year":"2014","unstructured":"Ma Q, Yu T, Ren YY, Gong T, Zhong DS. Overexpression of SAMD9 suppresses tumorigenesis and progression during non small cell lung cancer. Biochem Biophys Res Commun. 2014;454:157\u201361.","journal-title":"Biochem Biophys Res Commun"}],"container-title":["BMC Medical Genetics"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s12881-018-0546-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,3,4]],"date-time":"2019-03-04T19:34:16Z","timestamp":1551728056000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmcmedgenet.biomedcentral.com\/articles\/10.1186\/s12881-018-0546-4"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,3,5]]},"references-count":19,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2018,12]]}},"alternative-id":["546"],"URL":"https:\/\/doi.org\/10.1186\/s12881-018-0546-4","relation":{},"ISSN":["1471-2350"],"issn-type":[{"value":"1471-2350","type":"electronic"}],"subject":[],"published":{"date-parts":[[2018,3,5]]},"assertion":[{"value":"5 December 2017","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"23 February 2018","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"5 March 2018","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"This study was approved by the Institutional Review Board and Ethics Committee of Asan Medical Center. Written, informed consent to participate was obtained for all participants, or their guardians, before blood samples were drawn.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Written consent was obtained from the parents of patient for the publication, including child\u2019s data.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare that they have no competing interests.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}},{"value":"Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Publisher\u2019s Note"}}],"article-number":"35"}}